Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
66.80
+1.20 (1.83%)
Jul 24, 2026, 5:29 PM CET

STO:IBT.B Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-75-69-145.34-134.62-65.81-44.58
Depreciation & Amortization
0.820.820.820.820.820.82
Stock-Based Compensation
-0.24----
Other Adjustments
231.4610.8713.8813.62-32.64-19.26
Change in Receivables
4.16-2.385.28-9.317.154.34
Changes in Other Operating Activities
6.14-12.8923.1228.274.693.06
Operating Cash Flow
-56.78-72.34-113.13-101.22-85.8-55.62
Other Investing Activities
-----0.02-
Investing Cash Flow
-----0.02-
Issuance of Common Stock
--2.01101.551.90.09
Net Common Stock Issued (Repurchased)
--2.01101.551.90.09
Other Financing Activities
----5.03--
Financing Cash Flow
-02.0196.521.880.09
Effect of Exchange Rate Changes on Cash and Cash Equivalents
349.77.045.452.073318.85
Net Cash Flow
-56.78-72.34-111.12-4.7-83.91-55.53
Free Cash Flow
-56.78-72.34-113.13-101.22-85.8-55.62
FCF Margin
---2828330.00%-131453.00%-714958.00%-59173.40%
Free Cash Flow Per Share
-4.21-5.37-9.15-8.19-7.64-4.95
Levered Free Cash Flow
-64.4-77.24-112.97-93.99-59.95-41.12
Unlevered Free Cash Flow
-68.04-81.07-121.4-105.53-60.3-40.7